FDA
-
-
-
-
-
-
-
iRhythm study shows home cardiac monitoring increases AFib detection
-
-
-
-
-
-
-
Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer
-
-
-
-
-
-
-
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
-
-
-
-
-
-
-
iRhythm Technologies (IRTC) Receives FDA 510(k) Clearance
-
-
-
-
-
-
-
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
-
-
-
-
-
-
-
IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against iRhythm
-
-
-
-
-
-
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

